Fidelity Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119M | Buy |
596,127
+16,972
| +3% | +$3.36M | 0.01% | 1099 |
|
|
2025
Q4 | $110M | Buy |
579,155
+121,924
| +27% | +$23.4M | 0.01% | 1134 |
|
|
2025
Q3 | $81M | Buy |
457,231
+431,008
| +1,644% | +$64.1M | ﹤0.01% | 1267 |
|
|
2025
Q2 | $2.98M | Buy |
26,223
+1,290
| +5% | +$138K | ﹤0.01% | 2348 |
|
|
2025
Q1 | $2.62M | Buy |
24,933
+6,102
| +32% | +$690K | ﹤0.01% | 2358 |
|
|
2024
Q4 | $2.02M | Buy |
18,831
+6,082
| +48% | +$688K | ﹤0.01% | 2444 |
|
|
2024
Q3 | $1.28M | Buy |
12,749
+10,789
| +550% | +$1.09M | ﹤0.01% | 2532 |
|
|
2024
Q2 | $165K | Buy |
1,960
+152
| +8% | +$12.1K | ﹤0.01% | 3099 |
|
|
2024
Q1 | $132K | Sell |
1,808
-8,185
| -82% | -$603K | ﹤0.01% | 3177 |
|
|
2023
Q4 | $714K | Buy |
9,993
+9,655
| +2,857% | +$570K | ﹤0.01% | 2569 |
|
|
2023
Q3 | $20.3K | Sell |
338
-221
| -40% | -$14.5K | ﹤0.01% | 3794 |
|
|
2023
Q2 | $40.3K | Sell |
559
-7
| -1% | -$525 | ﹤0.01% | 3539 |
|
|
2023
Q1 | $41.6K | Buy |
566
+156
| +38% | +$11.1K | ﹤0.01% | 3528 |
|
|
2022
Q4 | $27.4K | Sell |
410
-885
| -68% | -$57.5K | ﹤0.01% | 3659 |
|
|
2022
Q3 | $70K | Buy |
1,295
+51
| +4% | +$3K | ﹤0.01% | 3363 |
|
|
2022
Q2 | $69K | Sell |
1,244
-686
| -36% | -$38.9K | ﹤0.01% | 3449 |
|
|
2022
Q1 | $135K | Buy |
1,930
+1,258
| +187% | +$91.3K | ﹤0.01% | 3356 |
|
|
2021
Q4 | $64K | Sell |
672
-6
| -0.9% | -$554 | ﹤0.01% | 3178 |
|
|
2021
Q3 | $59K | Sell |
678
-1,125
| -62% | -$87K | ﹤0.01% | 3176 |
|
|
2021
Q2 | $148K | Buy |
1,803
+24
| +1% | +$2K | ﹤0.01% | 2975 |
|
|
2021
Q1 | $169K | Buy |
1,779
+330
| +23% | +$31.2K | ﹤0.01% | 2847 |
|
|
2020
Q4 | $90K | Sell |
1,449
-335
| -19% | -$19.1K | ﹤0.01% | 2897 |
|
|
2020
Q3 | $107K | Sell |
1,784
-4,984
| -74% | -$340K | ﹤0.01% | 2782 |
|
|
2020
Q2 | $472K | Sell |
6,768
-11,594
| -63% | -$735K | ﹤0.01% | 2517 |
|
|
2020
Q1 | $832K | Sell |
18,362
-73,192
| -80% | -$4.15M | ﹤0.01% | 2359 |
|
|
2019
Q4 | $5.96M | Sell |
91,554
-13,652
| -13% | -$912K | ﹤0.01% | 2007 |
|
|
2019
Q3 | $6.53M | Sell |
105,206
-98,859
| -48% | -$6.21M | ﹤0.01% | 1968 |
|
|
2019
Q2 | $14.5M | Sell |
204,065
-243,982
| -54% | -$18M | ﹤0.01% | 1750 |
|
|
2019
Q1 | $35.1M | Sell |
448,047
-95,280
| -18% | -$7.22M | ﹤0.01% | 1367 |
|
|
2018
Q4 | $46M | Sell |
543,327
-316,894
| -37% | -$33.8M | 0.01% | 1178 |
|
|
2018
Q3 | $147M | Buy |
860,221
+153,965
| +22% | +$23.2M | 0.02% | 784 |
|
|
2018
Q2 | $91.3M | Buy |
706,256
+22,469
| +3% | +$2.51M | 0.01% | 999 |
|
|
2018
Q1 | $70.5M | Sell |
683,787
-5,317
| -0.8% | -$526K | 0.01% | 1138 |
|
|
2017
Q4 | $58.9M | Sell |
689,104
-163,828
| -19% | -$14.2M | 0.01% | 1220 |
|
|
2017
Q3 | $72.4M | Buy |
852,932
+209,788
| +33% | +$16.6M | 0.01% | 1125 |
|
|
2017
Q2 | $48.7M | Sell |
643,144
-36,629
| -5% | -$2.56M | 0.01% | 1292 |
|
|
2017
Q1 | $44.9M | Sell |
679,773
-99,386
| -13% | -$6.54M | 0.01% | 1359 |
|
|
2016
Q4 | $49.4M | Sell |
779,159
-759,822
| -49% | -$47.9M | 0.01% | 1302 |
|
|
2016
Q3 | $98M | Sell |
1,538,981
-152,926
| -9% | -$11.2M | 0.01% | 987 |
|
|
2016
Q2 | $126M | Buy |
1,691,907
+128,560
| +8% | +$9.54M | 0.02% | 870 |
|
|
2016
Q1 | $104M | Sell |
1,563,347
-216,885
| -12% | -$13.2M | 0.01% | 945 |
|
|
2015
Q4 | $120M | Buy |
1,780,232
+113,333
| +7% | +$7M | 0.02% | 882 |
|
|
2015
Q3 | $89.1M | Buy |
1,666,899
+33,070
| +2% | +$2.01M | 0.01% | 1001 |
|
|
2015
Q2 | $103M | Buy |
1,633,829
+6,316
| +0.4% | +$345K | 0.01% | 1029 |
|
|
2015
Q1 | $78.3M | Buy |
1,627,513
+105,195
| +7% | +$4.03M | 0.01% | 1141 |
|
|
2014
Q4 | $50.5M | Sell |
1,522,318
-744,273
| -33% | -$24.2M | 0.01% | 1322 |
|
|
2014
Q3 | $66.4M | Sell |
2,266,591
-488,142
| -18% | -$16.2M | 0.01% | 1170 |
|
|
2014
Q2 | $107M | Buy |
2,754,733
+86,081
| +3% | +$3.49M | 0.01% | 963 |
|
|
2014
Q1 | $112M | Hold |
2,668,652
| – | – | 0.02% | 926 |
|
|
2013
Q4 | $87.6M | Hold |
2,668,652
| – | – | 0.01% | 1046 |
|
|
2013
Q3 | $72.1M | Buy |
2,668,652
+711,251
| +36% | +$20M | 0.01% | 1103 |
|
|
2013
Q2 | $45.7M | Buy |
+1,957,401
| New | +$35.2M | 0.01% | 1284 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Fidelity Investments's LGND Position: Q1 2026 in Review
Fidelity Investments increased its Ligand Pharmaceuticals (LGND) stake by 2.9% in Q1 2026, buying an estimated $3.36M and bringing the position to 596,127 shares worth $119M. The position accounts for 0.01% of the portfolio, ranked #1099.
Fidelity Investments first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $147M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Fidelity Investments held 596,127 shares of Ligand Pharmaceuticals worth $119M as of Q1 2026.
- Fidelity Investments bought 16,972 Ligand Pharmaceuticals shares in Q1 2026, an estimated $3.36M.
- Ligand Pharmaceuticals made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #1099 holding.
- Fidelity Investments first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Ligand Pharmaceuticals position peaked at $147M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.